BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27325688)

  • 1. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
    Bennesch MA; Segala G; Wider D; Picard D
    Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1.
    Kim J; Park UH; Moon M; Um SJ; Kim EJ
    FEBS Lett; 2013 Jan; 587(1):17-22. PubMed ID: 23178685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.
    Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA.
    Ombra MN; Di Santi A; Abbondanza C; Migliaccio A; Avvedimento EV; Perillo B
    Biochim Biophys Acta; 2013 May; 1829(5):480-6. PubMed ID: 23507259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.
    Carascossa S; Dudek P; Cenni B; Briand PA; Picard D
    Genes Dev; 2010 Apr; 24(7):708-19. PubMed ID: 20360387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.
    Moore RL; Faller DV
    J Endocrinol; 2013 Mar; 216(3):273-85. PubMed ID: 23169992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms.
    Sun Y; Chung HH; Woo AR; Lin VC
    Biochim Biophys Acta; 2014 Sep; 1843(9):2067-78. PubMed ID: 24742914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
    Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin represses estrogen receptor α transactivation in breast cancer cells.
    Barrios-García T; Tecalco-Cruz A; Gómez-Romero V; Reyes-Carmona S; Meneses-Morales I; León-Del-Río A
    J Biol Chem; 2014 May; 289(22):15554-65. PubMed ID: 24737323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.
    Cui Y; Niu A; Pestell R; Kumar R; Curran EM; Liu Y; Fuqua SA
    Mol Endocrinol; 2006 Sep; 20(9):2020-35. PubMed ID: 16645043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
    Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
    Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
    Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ
    J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α.
    Purcell DJ; Chauhan S; Jimenez-Stinson D; Elliott KR; Tsewang TD; Lee YH; Marples B; Lee DY
    Mol Endocrinol; 2015 Dec; 29(12):1708-19. PubMed ID: 26505218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.